Candel Therapeutics, Inc. (CADL) Social Stream
CANDEL THERAPEUTICS INC (CADL) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering CADL.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-15 | 3 | $22 | $9 | $15.5 | $1.51 | 926.49% |
| 2021-11-19 | 3 | $22 | $9 | $16.333 | $1.51 | 981.66% |
| 2022-06-15 | 2 | $22 | $12 | $17 | $1.51 | 1025.83% |
| 2022-12-02 | 2 | $22 | $11 | $15 | $1.51 | 893.38% |
| 2023-05-22 | 2 | $22 | $11 | $16.5 | $1.51 | 992.72% |
The Trend in the Analyst Price Target
CADL's average price target has moved up $2.17 over the prior 49 weeks.
CADL reports an average of 496.51% for its upside potential over the past 49 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-06-15 | 3 | 22 | 12 | 17.000 | 3.46 | 391.33% |
| 2022-06-15 | 1 | 22 | 9 | 14.333 | 3.46 | 314.25% |
| 2022-12-02 | 2 | 22 | 11 | 16.500 | 1.88 | 777.66% |
| 2022-12-02 | 2 | 22 | 11 | 15.000 | 1.88 | 697.87% |
| 2023-05-22 | 2 | 22 | 11 | 16.500 | 1.69 | 876.33% |
CADL Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 2 | 0 | 0 | 0 | 0 | 2 |
The Trend in the Broker Recommendations
CADL's average broker recommendation rating improved by 0 over the prior 18 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- CANDEL THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 869.49% of all US stocks.
- In terms of how CANDEL THERAPEUTICS INC fares relative to all US stocks, note that its number of analysts covering the stock is higher than 46.4% of that group.
- CANDEL THERAPEUTICS INC's variance in analysts' estimates is lower than -550.81% of stocks in the small market cap category.
- In the context of Healthcare stocks, CANDEL THERAPEUTICS INC's average analyst price target is higher than 266.08% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to CANDEL THERAPEUTICS INC are ICVX, OMGA, and TNYA.
View All Top Stocks by Price Target
What is the outlook for CADL? Use POWR Ratings for clearer insight into price direction.